U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
113101113101A Study Combining ABT-888, Oral PARP Inhibitor, With Temozolomide in Patients With Metastatic Prostate CancerCompletedNo Results AvailableProstate CancerDrug: ABT-888|Drug: temozolomidehttps://ClinicalTrials.gov/show/NCT01085422
113102113102The Q in the Quality Adjusted Life Years (QALY): Exploring New MethodsCompletedNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT01085409
113103113103Use of Fiber-optic Probe for Non-invasive Diagnosis of Melanoma and Assessment of Impact of Ultraviolet (UV) Exposure on SkinTerminatedNo Results AvailableMelanomahttps://ClinicalTrials.gov/show/NCT01085396
113104113104Aripiprazole and Prolactin StudyCompletedNo Results AvailableHyperprolactinemiaDrug: Aripiprazolehttps://ClinicalTrials.gov/show/NCT01085383
113105113105Psychological Interventions in Children After Road Traffic Accidents or BurnsCompletedNo Results AvailableAcute Stress DisorderOther: Early psychological interventionhttps://ClinicalTrials.gov/show/NCT01085370
113106113106Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract SurgeryCompletedNo Results AvailablePrimary Open Angle Glaucoma (POAG)|CataractProcedure: Cataract Surgery|Device: CyPass Micro-Stenthttps://ClinicalTrials.gov/show/NCT01085357
113107113107Canadian Hemophilia Prophylaxis StudyCompletedNo Results AvailableSevere Hemophilia ABiological: Recombinant Factor VIII (Advate/Helixate FS/KoegenateFS)|Biological: Recombinant Factor VIII (Advate/Helixate FS/KoegenateFS)https://ClinicalTrials.gov/show/NCT01085344
113108113108MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)CompletedNo Results AvailableMetastatic Colorectal CancerDrug: Mek Inhibitor MSC1936369B|Drug: Mek Inhibitor MSC1936369B|Drug: Placebo|Drug: FOLFIRIhttps://ClinicalTrials.gov/show/NCT01085331
113109113109Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot TrialCompletedHas ResultsMultiple SclerosisDrug: Rebifhttps://ClinicalTrials.gov/show/NCT01085318
113110113110The Effectiveness of Parent-Child Interaction Therapy (PCIT)CompletedNo Results AvailableBehavior Problems|Oppositional Defiant Disorder|Conduct DisorderBehavioral: Parent-Child Interaction Therapy|Behavioral: TAUhttps://ClinicalTrials.gov/show/NCT01085305
113111113111NOX-E36 Multiple Ascending Dose Study in Healthy Volunteers and Patients With Type 2 Diabetes MellitusCompletedNo Results AvailableType 2 Diabetes MellitusDrug: NOX-E36|Drug: NOX-E36https://ClinicalTrials.gov/show/NCT01085292
113112113112Fractional Laser as Treatment Option for Various Pigment Disorders (Fractional-3)CompletedNo Results AvailablePigmentation DisorderDevice: Fraxel Restore, Solta Medical Inc. (Non-ablative fractional laser)|Drug: Modified Kligman's formula (Triple topical therapy)https://ClinicalTrials.gov/show/NCT01085279
113113113113An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington DiseaseCompletedNo Results AvailableHuntington DiseaseDrug: Dimebon (latrepirdine)https://ClinicalTrials.gov/show/NCT01085266
113114113114Nucleipark:High Field MR Imaging (7T and 3T) of the Brainstem, the Deep Nuclei and Their Connections in the Parkinsonian Syndromes. Applications to Prognosis, Pathophysiology and Improvement of Therapeutic StrategiesRecruitingNo Results AvailableParkinson's Disease|MRIOther: 3T and 7T MR imaginghttps://ClinicalTrials.gov/show/NCT01085253
113115113115Getting on With the Rest of Your Life After a StrokeActive, not recruitingNo Results AvailableStrokeOther: Mission Possiblehttps://ClinicalTrials.gov/show/NCT01085240
113116113116Clinical, Molecular and by Neuroimaging of LRRK2 MutationsRecruitingNo Results AvailableParkinson's Diseasehttps://ClinicalTrials.gov/show/NCT01085227
113117113117AZD6244 (Selumetinib) in Treating Patients With Multiple MyelomaCompletedHas ResultsRecurrent Plasma Cell Myeloma|Refractory Plasma Cell MyelomaOther: Laboratory Biomarker Analysis|Drug: Selumetinibhttps://ClinicalTrials.gov/show/NCT01085214
113118113118Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell DiseaseCompletedHas ResultsSickle Cell DiseaseDrug: Lexiscanhttps://ClinicalTrials.gov/show/NCT01085201
113119113119Effectiveness of Assertive Continuing Care for YouthCompletedNo Results AvailableSubstance Use DisordersBehavioral: ACC|Behavioral: CM|Behavioral: UCChttps://ClinicalTrials.gov/show/NCT01085188
113120113120Trial to Determine Imaging Parameters of LMI1195 in Heart Failure Patients at Low and High Risk of Defibrillator FiringWithdrawnNo Results AvailableHeart FailureDrug: LMI 1195https://ClinicalTrials.gov/show/NCT01085175
113121113121A Long-term Follow-up Study to Evaluate the Predictive Value of BMS747158 in Patients Suspected of Coronary Artery Disease (CAD)WithdrawnNo Results AvailableCoronary Artery Disease (CAD)Drug: BMS747158https://ClinicalTrials.gov/show/NCT01085162
113122113122The Effect Of Simvastatin On Bone Remodeling In Socket Of Mandibular TeethNot yet recruitingNo Results AvailableHypercholesterolemiaDrug: Simvastatinhttps://ClinicalTrials.gov/show/NCT01085149
113123113123LUX-Lung 5: Afatinib (BIBW 2992) Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or GefitinibActive, not recruitingHas ResultsCarcinoma, Non-Small-Cell LungDrug: Investigator´s choice of chemotherapy|Drug: BIBW 2992https://ClinicalTrials.gov/show/NCT01085136
113124113124Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male VolunteersCompletedNo Results AvailableMigraineDrug: Rapimelt|Drug: [11C]AZ10419369https://ClinicalTrials.gov/show/NCT01085123
113125113125Persistent Pain After Laparoscopic Inguinal Hernia RepairCompletedNo Results AvailablePain, Postoperative|Neuropathic Pain|Postherniotomy Painhttps://ClinicalTrials.gov/show/NCT01085110
113126113126Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus NephritisCompletedNo Results AvailableLupus NephritisDrug: laquinimod|Drug: Mycophenolate Mofetil|Drug: corticosteroids|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01085097
113127113127Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus ArthritisCompletedNo Results AvailableLupus ArthritisDrug: Laquinimod|Drug: Laquinimod|Other: Placebohttps://ClinicalTrials.gov/show/NCT01085084
113128113128Comparison of Two Potassium Targets Within the Normal Range in Intensive Care PatientsCompletedNo Results AvailableThoracic Surgery|Cardiac Surgery|Critically IllDrug: Potassium Chloride|Drug: Potassium Chloridehttps://ClinicalTrials.gov/show/NCT01085071
113129113129Predictive Value of the "Cytocapacity Test" Patients With Lymphoproliferative Diseases and High-dose TherapyCompletedNo Results AvailableHodgkin's Disease|Non-Hodgkin Lymphomas|Multiple MyelomasDrug: lenograstimhttps://ClinicalTrials.gov/show/NCT01085058
113130113130Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNo Results AvailableChronic Obstructive Pulmonary DiseaseDrug: PT003 MDI|Drug: PT005 MDI|Drug: Placebo MDI|Drug: Tiotropium bromide 18 μg (Spiriva Handihaler®)|Drug: Formoterol Fumarate 12 μg (Foradil® Aerolizer®)|Drug: PT001 MDIhttps://ClinicalTrials.gov/show/NCT01085045

* Görseller ve İçerik tekif hakkına sahip olabilir